News & Events

white plant

NEWS

InPP took part in the kick-off meeting for the European PROSPER project, held on October 2 and 3 in Pavia, Italy. In attendance were the director of the Monitoring and Diagnostics Department, Ilaria Marengo, and the project manager, Bruno Orrico.

PROSPER's main objective is to transform European agriculture by valorizing highly resilient “orphan” legumes - forgotten crops, but full of potential to face the climate and food challenges of the future.

The project promotes sustainable, innovative practices adapted to different agricultural realities.

Over the two days, 27 partners from 13 countries met for presentations, in-depth discussions and strategic talks about the project's next steps.

We are excited about what comes next, certain that this journey will be more than a collaboration - it will be a true cooperation within an exceptional team.

Join us and keep up to date with all the news from the PROSPER Project!

InnovPlantProtect (InPP) was present at the project launch meeting BioLivingLABS - Bioeconomia ao Serviço da Sustentabilidade dos Territórios do Interior (Bioeconomy at the Service of the Sustainability of Inland Territories), which took place on October 1st at the School of Agriculture of the Polytechnic Institute of Castelo Branco (IPCB).

Funded by COMPETE 2023, the BioLivingLABS project, led by MORE CoLAB - Laboratório Colaborativo Montanhas de Investigação, in partnership with the InPP, the IPCB, from AQUAVALOR and the Polytechnic Institute of Bragança (IPB).

This project's mission is to add value to the low-density territories in the north, center and south of the country by demonstrating and economically boosting the work carried out by the partners - through the creation, demonstration and application of products, processes and services resulting from joint research.

Four living laboratories will be created (Living Labs) in the innovation hubs of Mirandela, Douro, Covilhã and Elvas, which they intend to promote:

  • the transfer of knowledge;
  • technology demonstration;
  • strategic roadmapping and
  • the protection of intellectual property.

BioLivingLABS strengthens the link between academia, business and society, driving innovation and sustainability.

Expected impact:
Over the course of 24 months, and with Living Labs dedicated to sectors such as olive groves and olive oil, vineyards and wine, fruit and cereals, legumes, among others, the project will contribute to:

  • increase regional competitiveness;
  • promote sustainable practices and
  • responding to the environmental, social and economic challenges facing inland territories.

More news about this new project soon.

On September 25, InnovPlantProtect (InPP) was present at the National Exhibition of Blue Bioeconomy Pact Projects, held at the Port of Leixões Cruise Terminal, for the exhibition session of the Algae Vertical project, led by PhytoBloom by Necton.

InPP, leader of sub-project 6 - Agriculture, was represented by department director Cristina Azevedo and executive director António Saraiva, who presented some of the new algae-based biosolutions that our team and partners are developing.

There were more than 300 participants and 80 entities, including companies, research centers and political decision-makers. The Opening Conference was attended by the Chairman of Inovamar's General and Supervisory Board, José Soares dos Santos, and round tables were held on the future of the blue economy in Portugal.

Algae Vertical explores the biotechnological potential of algae in sectors as diverse as food, cosmetics, pharmaceuticals, agriculture and energy.

Find out more about the Algae Vertical Project here

EVENTS

The Department of Formulations and Process Development for the Application of Biopesticides is dedicated to the design and production of encapsulation and transport systems, suitable for protecting our biological agents from the degradation that occurs during prolonged storage and during application. These protective and carrier systems, which are nanometric and micrometric in size, will be incorporated into solid and liquid formulations in a format that adapts to the specific agricultural application for which they have been designed.

Formulations can be solid or liquid.

After understanding the specific needs of each bioagent, we adjust the characteristics of the respective transport systems accordingly and also focus on developing viable manufacturing processes, potentially scalable to industrial volumes.

Solid nanoparticles, lipid nanoemulsions and polymeric microcapsules will be developed, obtained using precise and sophisticated processes already adopted by the industry. Innovation will be sought through the use of sustainable ingredients and combinations with previous systems, for easier adoption by the biocontrol market.

Image by Hans Reniers | Unsplash

“The current legislation on GMOs [genetically modified organisms], adopted in 2001, is not suitable for the new genomic techniques (NTG),” says the long-awaited study published by the European Commission (EC) at the request of the Council of the European Union (EU). O document led the EC to announce which will “initiate a broad and open consultation process to discuss the design of a new legal framework for these biotechnologies”.

“The study shows that NTG, which are techniques for altering the genome of an organism, have the potential to contribute to a more sustainable food system within the framework of the objectives of the European Green Deal and Farm to Fork Strategy“, says the EC statement. “With consumer and environmental safety as the guiding principle, the time has come to establish an open dialogue with citizens, Member States and the European Parliament in order to decide together on the way forward for the use of these biotechnologies in the EU,” stresses Stella Kyriakides, Commissioner for Health and Food Safety.

“NTGs have the potential to contribute to a more sustainable food system.”

The report identifies limitations to the legislation's ability to keep up with scientific developments, causing implementation challenges and illegal uncertainties, which need to be resolved. It recognizes that it may not be justifiable to apply different levels of regulatory oversight to products with similar degrees of risk, as in the case of conventionally improved plants and those obtained from certain NTGs.

“Future regulatory actions will need to address the knowledge gaps and limitations identified in this study.” In addition, “a greater effort should be made to inform and involve the public regarding NGTs, and to assess their opinions,” admits the EC.

Entitled ‘Study on the status of new genomic techniques under Union law and in light of the Court of Justice ruling in Case C-528/16’, the study examines the current state of NTG, “taking into account the ‘state of the art’ of knowledge and the views of EU countries and stakeholders”. The Council of the EU requested this state of play on NTG under European law (Directive 2001/18/ECRegulation (EC) 1829/2003Directive 2009/41/EC e Regulation (EC) 1830/2003), in the light of the judgment of the Court of Justice in Case C-528/16.

Image by Congerdesign | Pixabay

“The current GMO legislation, adopted in 2001, is not fit for purpose for New Genomic Techniques (NGTs)”, says the awaited study published by the European Commission (EC), at the request of the EU Council. The document prompted the EC to announce the start of a “wide and open consultation process to discuss the design of a new legal framework for these biotechnologies”.

“The study shows that NGTs, which are techniques to alter the genome of an organism, have the potential to contribute to a more sustainable food system as part of the objectives of the European Green Deal and the Farm to Fork Strategy”, states the EC in the related press release. “With the safety of consumers and the environment as the guiding principle, now is the moment to have an open dialogue with citizens, Member States and the European Parliament to jointly decide the way forward for the use of these biotechnologies in the EU”, emphasizes Stella Kyriakides, Commissioner for Health and Food Safety.

The study identifies limitations to the capacity of legislation to keep pace with scientific developments, causing implementation challenges and legal uncertainties, which need to be addressed. It recognizes it may not be justified to apply different levels of regulatory oversight to similar products with similar levels of risk, as is the case for plants conventionally bred and obtained from certain NGTs.

“Future policy action would need to address the knowledge gaps and limitations identified in this study”. Furthermore, “importantly, more effort should be made to inform and engage with the public on NGTs and assess their views”, admits the EC.

Entitled ‘Study on the status of new genomic techniques under Union law and in light of the Court of Justice ruling in Case C-528/16’, the report examines the status of NGTs “taking into account the state of the art knowledge and the views of the EU countries and stakeholders”. The Council of the European Union asked for this study, regarding the status of new genomic techniques under Union Law (Directive 2001/18/ECRegulation (EC) 1829/2003Directive 2009/41/EC and Regulation (EC) 1830/2003), in light of the Court of Justice's judgment in Case C-528/16.

Image by Congerdesign, from Pixabay